Frontlight ResearchEarly access
Trial site
Azienda Ospedaliera di Perugia;Ospedale S. Maria della Misericordia
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Acute myeloid leukaemia2 trials
- Melanoma2 trials
- Type 2 diabetes2 trials
- Alzheimer disease1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Macular degeneration1 trial
- Mild cognitive impairment1 trial
- and 8 more
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Novo Nordisk A/S4 trials
- Antonio Pierini1 trial
- Eli Lilly and Company1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026